Treatment of Acanthamoeba Encephalitis.
Publication
, Journal Article
Wolf, MA; Thielman, NM; Kraft, BD
Published in: Am J Med
January 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Am J Med
DOI
EISSN
1555-7162
Publication Date
January 2022
Volume
135
Issue
1
Start / End Page
e20 / e21
Location
United States
Related Subject Headings
- Middle Aged
- Male
- Infectious Encephalitis
- Humans
- General & Internal Medicine
- Fatal Outcome
- Drug Therapy, Combination
- Central Nervous System Protozoal Infections
- Anti-Infective Agents
- Acanthamoeba
Citation
APA
Chicago
ICMJE
MLA
NLM
Wolf, M. A., Thielman, N. M., & Kraft, B. D. (2022). Treatment of Acanthamoeba Encephalitis. Am J Med, 135(1), e20–e21. https://doi.org/10.1016/j.amjmed.2021.08.009
Wolf, Monroe A., Nathan M. Thielman, and Bryan D. Kraft. “Treatment of Acanthamoeba Encephalitis.” Am J Med 135, no. 1 (January 2022): e20–21. https://doi.org/10.1016/j.amjmed.2021.08.009.
Wolf MA, Thielman NM, Kraft BD. Treatment of Acanthamoeba Encephalitis. Am J Med. 2022 Jan;135(1):e20–1.
Wolf, Monroe A., et al. “Treatment of Acanthamoeba Encephalitis.” Am J Med, vol. 135, no. 1, Jan. 2022, pp. e20–21. Pubmed, doi:10.1016/j.amjmed.2021.08.009.
Wolf MA, Thielman NM, Kraft BD. Treatment of Acanthamoeba Encephalitis. Am J Med. 2022 Jan;135(1):e20–e21.
Published In
Am J Med
DOI
EISSN
1555-7162
Publication Date
January 2022
Volume
135
Issue
1
Start / End Page
e20 / e21
Location
United States
Related Subject Headings
- Middle Aged
- Male
- Infectious Encephalitis
- Humans
- General & Internal Medicine
- Fatal Outcome
- Drug Therapy, Combination
- Central Nervous System Protozoal Infections
- Anti-Infective Agents
- Acanthamoeba